Side-by-side comparison of AI visibility scores, market position, and capabilities
CFTC-designated contract market for event-based prediction futures, acquired by DraftKings in October 2025; YC W22-backed with ex-Point72 team achieving federal exchange status for hedging and prediction markets.
Railbird was an Austin, Texas-based CFTC-regulated prediction market exchange enabling businesses and traders to hedge commercial risk through event-based futures contracts — founded in 2021 and backed by Y Combinator (W22). Staffed by former Point72 analysts, Railbird achieved designated contract market (DCM) status from the CFTC in June 2025 (one of the first CFTC-regulated prediction market exchanges to receive full DCM designation) and was subsequently acquired by DraftKings in October 2025, bringing Railbird's regulated prediction market infrastructure into the sports betting giant's portfolio.
Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.
Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.